Cargando…

Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia

To estimate multipliers linking surveillance of salmonellosis, campylobacteriosis, and Shiga toxin–producing Escherichia coli (STEC) infections to community incidence, we used data from a gastroenteritis survey and other sources. Multipliers for severe (bloody stool/long duration) and milder cases w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Gillian, Yohannes, Keflemariam, Raupach, Jane, Becker, Niels, Kirk, Martyn
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2609882/
https://www.ncbi.nlm.nih.gov/pubmed/18826825
http://dx.doi.org/10.3201/eid1410.071042
_version_ 1782163065582649344
author Hall, Gillian
Yohannes, Keflemariam
Raupach, Jane
Becker, Niels
Kirk, Martyn
author_facet Hall, Gillian
Yohannes, Keflemariam
Raupach, Jane
Becker, Niels
Kirk, Martyn
author_sort Hall, Gillian
collection PubMed
description To estimate multipliers linking surveillance of salmonellosis, campylobacteriosis, and Shiga toxin–producing Escherichia coli (STEC) infections to community incidence, we used data from a gastroenteritis survey and other sources. Multipliers for severe (bloody stool/long duration) and milder cases were estimated from the component probabilities of doctor visit, stool test, sensitivity of laboratory test, and reporting to surveillance system. Pathogens were classified by the same severity criteria and appropriate multipliers applied. Precision of estimates was quantified by using simulation techniques to construct 95% credible intervals (CrIs). The multiplier for salmonellosis was estimated at 7 (95% CrI 4–16), for campylobacteriosis at 10 (95% CrI 7–22), and for STEC at 8 (95% CrI 3–75). Australian annual community incidence rates per 100,000 population were estimated as 262 (95% CrI 150–624), 1,184 (95% CrI 756–2,670), and 23 (95% CrI 13–54), respectively. Estimation of multipliers allows assessment of the true effects of these diseases and better understanding of public health surveillance.
format Text
id pubmed-2609882
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-26098822009-01-13 Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia Hall, Gillian Yohannes, Keflemariam Raupach, Jane Becker, Niels Kirk, Martyn Emerg Infect Dis Research To estimate multipliers linking surveillance of salmonellosis, campylobacteriosis, and Shiga toxin–producing Escherichia coli (STEC) infections to community incidence, we used data from a gastroenteritis survey and other sources. Multipliers for severe (bloody stool/long duration) and milder cases were estimated from the component probabilities of doctor visit, stool test, sensitivity of laboratory test, and reporting to surveillance system. Pathogens were classified by the same severity criteria and appropriate multipliers applied. Precision of estimates was quantified by using simulation techniques to construct 95% credible intervals (CrIs). The multiplier for salmonellosis was estimated at 7 (95% CrI 4–16), for campylobacteriosis at 10 (95% CrI 7–22), and for STEC at 8 (95% CrI 3–75). Australian annual community incidence rates per 100,000 population were estimated as 262 (95% CrI 150–624), 1,184 (95% CrI 756–2,670), and 23 (95% CrI 13–54), respectively. Estimation of multipliers allows assessment of the true effects of these diseases and better understanding of public health surveillance. Centers for Disease Control and Prevention 2008-10 /pmc/articles/PMC2609882/ /pubmed/18826825 http://dx.doi.org/10.3201/eid1410.071042 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Hall, Gillian
Yohannes, Keflemariam
Raupach, Jane
Becker, Niels
Kirk, Martyn
Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title_full Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title_fullStr Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title_full_unstemmed Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title_short Estimating Community Incidence of Salmonella, Campylobacter, and Shiga Toxin–producing Escherichia coli Infections, Australia
title_sort estimating community incidence of salmonella, campylobacter, and shiga toxin–producing escherichia coli infections, australia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2609882/
https://www.ncbi.nlm.nih.gov/pubmed/18826825
http://dx.doi.org/10.3201/eid1410.071042
work_keys_str_mv AT hallgillian estimatingcommunityincidenceofsalmonellacampylobacterandshigatoxinproducingescherichiacoliinfectionsaustralia
AT yohanneskeflemariam estimatingcommunityincidenceofsalmonellacampylobacterandshigatoxinproducingescherichiacoliinfectionsaustralia
AT raupachjane estimatingcommunityincidenceofsalmonellacampylobacterandshigatoxinproducingescherichiacoliinfectionsaustralia
AT beckerniels estimatingcommunityincidenceofsalmonellacampylobacterandshigatoxinproducingescherichiacoliinfectionsaustralia
AT kirkmartyn estimatingcommunityincidenceofsalmonellacampylobacterandshigatoxinproducingescherichiacoliinfectionsaustralia